The COVID-19 global health emergency raised awareness of the importance of PCR testing and, as a result, people worldwide are now more willing to incorporate various diagnostics for monitoring their well-being and health into everyday life.
This webcast will introduce the Seegene Open Innovation Program, part of the OneSystem Business initiative to accelerate the development of innovative syndromic PCR assays with the involvement of scientists around the world. By developing assays across all fields, the collaboration will set the stage for making syndromic quantitative PCR tests more affordable and accessible.
Through this collaboration, Seegene will share technologies, know-how accumulated over 23 years, and grant funding via the Open Innovation Program with scientists and experts worldwide, enabling the development of a variety of customized products addressing local needs.
You will learn:
• How a collaboration in Italy to develop a PCR assay to identify drug-resistance in bacteria empowered the proposed collaborative global network
• Considerations for actualizing research data based on Seegene technologies and know-hows
•How Seegene OneSystem Business will respond proactively to emerging local healthcare demands and contribute to a disease-free world
Unable to join the live event? Watch on demand. Register now to ensure that you receive information on how to gain access after the live event.
This webcast has been produced by Seegene, who retails sole responsibility for content. About this content.
Speakers
Alberto Antonelli, Research Fellow, University of Florence, Italy
Alberto Antonelli received his PhD from the University of Siena in 2016. Since 2019, he has worked as a research fellow in the Department of Experimental and Clinical Medicine at the University of Florence. His current scientific interests are surveillance, molecular epidemiology and the clinical impact of microbial drug resistance and nosocomial infections.
Jik-Young Park, Institute of Development Automation, Seegene, Republic of Korea
Jik-Young Park received his PhD from Catholic University of Korea in 2003, and did postdoctoral research at NIH until 2008. After joining Seegene in 2011, he has been involved in the development of various molecular diagnostic products in R&D, and has been working on automation of the development process.
Moderator
Sarah Hiddleston, Nature Research Custom Media
Sarah Hiddleston is a freelance journalist who has worked with Nature Research Custom Media since 2015. Previously, Sarah worked for a decade in Madras (Chennai), India, specialising in health, pharmaceutical and environmental stories. Sarah holds an MA in Investigative Journalism from City University London, an MSc in Political Theory from the London School of Economics, and an undergraduate degree in History from the University of Cambridge, UK.
